| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $17.75M | $16.24M | $24.46M | $22.43M | $21.07M |
| R&D | – | – | – | – | – |
| SG&A | $615.66K | $597.88K | $638.35K | $835.91K | $521.54K |
| Operating Income | – | – | – | – | – |
| Interest Expense | $9.24M | $7.85M | $10.83M | $12.35M | $10.50M |
| Tax Expense | – | – | – | – | – |
| Net Income | -$18.73M | $5.88M | $17.24M | -$85.55M | $39.58M |
| EPS (basic) | 0.3000 | 0.4200 | 0.5100 | 0.4200 | 0.3200 |
| EPS (diluted) | 0.3000 | 0.4200 | 0.5100 | 0.4200 | 0.3200 |
| Shares (diluted) | $76.43M | $63.47M | $53.92M | $49.76M | $49.62M |